Valsartan benzyl ester
| Code | Size | Price |
|---|
| TAR-T20564-25mg | 25mg | £484.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T20564-50mg | 50mg | £679.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T20564-100mg | 100mg | £1,119.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Valsartan benzyl ester is a intermediate of Valsartan.
CAS:
137863-20-8
Formula:
C31H35N5O3
Molecular Weight:
525.653
Purity:
0.98
SMILES:
CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)[C@@H](C(C)C)C(=O)OCc1ccccc1
References
1. Ardiana F, Suciati, Indrayanto G. Valsartan. Profiles Drug Subst Excip Relat Methodol. 2015;40:431-93. doi: 10.1016/bs.podrm.2015.01.004. Epub 2015 Mar 21. Review. PubMed PMID: 26051690.
2. Jung JA, Lee SY, Kim JR, Ko JW, Jang SB, Nam SY, Huh W. A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects. Drug Des Devel Ther. 2015 Mar 2;9:745-52. doi: 10.2147/DDDT.S76942. eCollection 2015. PubMed PMID: 25767372; PubMed Central PMCID: PMC4354399.
3. Claggett B, Packer M, McMurray JJ, Swedberg K, Rouleau J, Zile MR, Jhund P, Lefkowitz M, Shi V, Solomon SD; PARADIGM-HF Investigators. Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan. N Engl J Med. 2015 Dec 3;373(23):2289-90. doi: 10.1056/NEJMc1509753. PubMed PMID: 26630151.
4. Zhi-Bin H, Chang F, Mao-Huan L, Gui-Yi Y, Shu-Xian Z, Wei W. Valsartan improves the electrophysiological characteristics of left ventricular hypertrophic myocardium in spontaneously hypertensive rats. Hypertens Res. 2014 Sep;37(9):824-9. doi: 10.1038/hr.2014.85. Epub 2014 Apr 24. PubMed PMID: 24758867.